Concepedia

Publication | Open Access

A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma

64

Citations

24

References

2016

Year

References

YearCitations

Page 1